| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 465,192 | 454,550 | 443,274 | 482,983 | | Cost of Revenue | 351,323 | 359,928 | 352,704 | 368,376 | | | Gross Profit | 113,869 | 94,622 | 90,570 | 114,607 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 65,551 | 65,155 | 62,378 | 75,016 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 48,318 | 29,467 | 28,192 | 39,591 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 359 | 377 | 133 | 146 | | Earnings Before Interest And Taxes | 48,677 | 29,844 | 28,325 | 39,737 | | Interest Expense | 5,360 | 5,501 | 7,119 | 6,260 | | Income Before Tax | 43,317 | 24,343 | 21,206 | 33,477 | | Income Tax Expense | 11,645 | 6,822 | 7,230 | 11,399 | | Minority Interest | (2,780) |
-
|
-
| (640) | | | | Net Income From Continuing Ops | 28,892 | 17,521 | 13,976 | 21,438 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,892 | 17,521 | 13,976 | 21,438 | | Preferred Stock And Other Adjustments | 2,258 | (1,069) | (1,189) |
-
| | | Net Income Applicable To Common Shares | $31,150 | $16,452 | $12,787 | $21,438 |
|
0.11% Nasdaq 
Income Statement
